Intravitreal dexamethasone implant therapy for the treatment of cystoid macular Oedema due to hydroxychloroquine retinopathy: a case report and literature review

BACKGROUND: Cystoid macular oedema (CMO) is an uncommon complication associated with hydroxychloroquine (HCQ) retinopathy threatening central vision. We report a patient with HCQ retinopathy and CMO, for which an intravitreal dexamethasone implant was used, which led to complete resolution of oedema...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Ophthalmol
Auteurs principaux: Ahn, Seong Joon, Joung, Jooyoung, Lee, Sang Hyup, Lee, Byung Ro
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2018
Sujets:
Case Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6282365/
https://ncbi.nlm.nih.gov/pubmed/30522457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-018-0985-x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires